Peter Vestergaard

26.3k total citations
537 papers, 19.4k citations indexed

About

Peter Vestergaard is a scholar working on Orthopedics and Sports Medicine, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Peter Vestergaard has authored 537 papers receiving a total of 19.4k indexed citations (citations by other indexed papers that have themselves been cited), including 207 papers in Orthopedics and Sports Medicine, 147 papers in Endocrinology, Diabetes and Metabolism and 131 papers in Oncology. Recurrent topics in Peter Vestergaard's work include Bone health and osteoporosis research (197 papers), Bone health and treatments (112 papers) and Vitamin D Research Studies (65 papers). Peter Vestergaard is often cited by papers focused on Bone health and osteoporosis research (197 papers), Bone health and treatments (112 papers) and Vitamin D Research Studies (65 papers). Peter Vestergaard collaborates with scholars based in Denmark, Netherlands and United Kingdom. Peter Vestergaard's co-authors include Leif Mosekilde, Lars Rejnmark, Lars Frost, Jakob Starup‐Linde, Lene Heickendorff, Bo Abrahamsen, Pia Eiken, Frank de Vries, Anne Pernille Hermann and Christine Brot and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Peter Vestergaard

512 papers receiving 18.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter Vestergaard 6.8k 4.3k 4.0k 3.7k 3.7k 537 19.4k
Peter R. Ebeling 6.8k 1.0× 4.4k 1.0× 5.0k 1.2× 3.1k 0.8× 5.6k 1.5× 568 23.6k
Leif Mosekilde 9.1k 1.3× 4.8k 1.1× 5.4k 1.3× 4.8k 1.3× 5.5k 1.5× 383 22.9k
Lars Rejnmark 4.5k 0.7× 4.9k 1.1× 2.5k 0.6× 2.9k 0.8× 3.6k 1.0× 322 14.5k
Markus J. Seibel 6.3k 0.9× 2.5k 0.6× 4.4k 1.1× 2.5k 0.7× 2.7k 0.7× 509 21.6k
Dan Mellström 11.1k 1.6× 5.0k 1.2× 5.4k 1.3× 2.7k 0.7× 2.2k 0.6× 314 19.9k
Eric Orwoll 15.9k 2.3× 7.2k 1.7× 6.8k 1.7× 5.1k 1.4× 4.3k 1.2× 499 33.2k
Steven Boonen 15.1k 2.2× 7.0k 1.6× 7.7k 1.9× 4.5k 1.2× 4.8k 1.3× 392 29.4k
Philip N. Sambrook 11.7k 1.7× 5.1k 1.2× 4.4k 1.1× 1.7k 0.5× 4.8k 1.3× 256 21.3k
Meryl S. LeBoff 6.7k 1.0× 3.2k 0.8× 3.0k 0.7× 1.5k 0.4× 2.6k 0.7× 187 15.2k
Karl Michaëlsson 4.7k 0.7× 3.8k 0.9× 1.6k 0.4× 1.1k 0.3× 4.0k 1.1× 325 16.6k

Countries citing papers authored by Peter Vestergaard

Since Specialization
Citations

This map shows the geographic impact of Peter Vestergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Vestergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Vestergaard more than expected).

Fields of papers citing papers by Peter Vestergaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Vestergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Vestergaard. The network helps show where Peter Vestergaard may publish in the future.

Co-authorship network of co-authors of Peter Vestergaard

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Vestergaard. A scholar is included among the top collaborators of Peter Vestergaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Vestergaard. Peter Vestergaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Røikjer, Johan, et al.. (2025). Symptom-driven co-existence of diabetic autonomic neuropathy, peripheral neuropathy, and painful neuropathy. Acta Diabetologica. 63(2). 193–199.
2.
Vestergaard, Peter, et al.. (2025). Skin Autofluorescence May Contribute to Prediction of Low Bone Quality in Type 1 Diabetes—A Clinical Cross‐Sectional Study. Diabetes/Metabolism Research and Reviews. 41(6). e70080–e70080. 1 indexed citations
3.
4.
Frost, Morten, et al.. (2025). Direct Healthcare Cost of Fractures in Patients With Type 1 Diabetes: A Population-Based Cohort Study in Denmark. The Journal of Clinical Endocrinology & Metabolism. 110(12). e4075–e4085. 1 indexed citations
5.
Vestergaard, Peter, et al.. (2024). Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma. Pituitary. 27(5). 723–730. 8 indexed citations
6.
Brøns, Charlotte, Verena Hirschberg, Torben Hansen, et al.. (2024). 1357-P: High Plasma Leptin Levels Are Associated with Low Birth Weight and Disease Severity in People with Recently Diagnosed Type 2 Diabetes. Diabetes. 73(Supplement_1). 1 indexed citations
7.
Tran, Thach, Dana Bliuc, Bo Abrahamsen, et al.. (2024). Multimorbidity clusters potentially superior to individual diseases for stratifying fracture risk in older people: a nationwide cohort study. Age and Ageing. 53(7). 2 indexed citations
8.
9.
Ejskjær, Niels, et al.. (2023). The co-existence of peripheral and vestibular neuropathy in diabetes: a cross-sectional study. European Archives of Oto-Rhino-Laryngology. 281(2). 663–672. 5 indexed citations
10.
Vestergaard, Peter, et al.. (2023). Site-Specific Fracture Incidence Rates Among Patients With Type 1 Diabetes, Type 2 Diabetes, or Without Diabetes in Denmark (1997–2017). Diabetes Care. 46(3). 633–642. 19 indexed citations
11.
Gormsen, Lars Christian, Lasse Hjort Jakobsen, Toby A. Eyre, et al.. (2023). The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study. British Journal of Haematology. 204(4). 1271–1278. 2 indexed citations
12.
13.
Vestergaard, Peter, et al.. (2023). Sex‐ and Age Group‐Specific Fracture Incidence Rates Trends for Type 1 and 2 Diabetes Mellitus. JBMR Plus. 7(11). e10836–e10836. 3 indexed citations
14.
Jensen, Paw, Lasse Hjort Jakobsen, Martin Bøgsted, et al.. (2022). A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment. Blood Advances. 6(8). 2549–2556. 7 indexed citations
15.
Bæch, Joachim, Marianne Tang Severinsen, Henrik Frederiksen, et al.. (2022). Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy. Blood Advances. 6(15). 4427–4435. 2 indexed citations
16.
Andersen, Stine Linding, et al.. (2021). 43rd Annual Meeting of the European Thyroid Association. Virtual Conference, September 4–7, 2021. European Thyroid Journal. 10(Suppl. 1). 1–56. 7 indexed citations
17.
Almdal, Thomas, Peter Vestergaard, Louise Lundby‐Christensen, et al.. (2021). Effect of metformin and insulin vs. placebo and insulin on whole body composition in overweight patients with type 2 diabetes: a randomized placebo-controlled trial. Osteoporosis International. 32(9). 1837–1848. 10 indexed citations
18.
Stengaard‐Pedersen, Kristian, Peter Vestergaard, Mikkel Østergaard, et al.. (2018). The D‐vitamin metabolite 1,25(OH)2D in serum is associated with disease activity and Anti‐Citrullinated Protein Antibodies in active and treatment naïve, early Rheumatoid Arthritis Patients. Scandinavian Journal of Immunology. 88(3). e12704–e12704. 18 indexed citations
19.
Pouwels, S., Arief Lalmohamed, Tjeerd van Staa, et al.. (2009). Use of organic nitrates and the risk of hip fracture: a population-based case-control study. ePrints Soton (University of Southampton). 6 indexed citations
20.
Vestergaard, Peter. (2001). FRACTURE RISK IN PATIENTS WITH MUSCULAR DYSTROPHY AND SPINAL MUSCULAR ATROPHY. Journal of Rehabilitation Medicine. 33(4). 150–155. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter R. Ebeling Breakdown of academic impact, for papers by Leif Mosekilde Breakdown of academic impact, for papers by Lars Rejnmark Breakdown of academic impact, for papers by Markus J. Seibel Breakdown of academic impact, for papers by Dan Mellström Breakdown of academic impact, for papers by Eric Orwoll Breakdown of academic impact, for papers by Steven Boonen Breakdown of academic impact, for papers by Philip N. Sambrook Breakdown of academic impact, for papers by Meryl S. LeBoff Breakdown of academic impact, for papers by Karl Michaëlsson
Rankless by CCL
2026